Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
Corcept Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 27, 2020
Corcept Therapeutics reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, four executives at Corcept Therapeutics received on average a compensation package of $3.4M, which is about the same as previous year.
Average pay of disclosed executives at Corcept Therapeutics
Joseph K. Belanoff, Chief Executive Officer, received $5M in total, which decreased by 21% compared to 2018. 71% of Belanoff's compensation, or $3.5M, was in option awards. Belanoff also received $745K in bonus and $708K in salary.
Andreas Grauer, Chief Medical Officer, received a compensation package of $3.8M. 82% of the compensation package, or $3.1M, was in option awards.
Charles Robb, Chief Financial Officer, earned $2.6M in 2019, a 8% decrease compared to previous year.
Sean Maduck, Senior Vice President, Commercial, received $2.2M in 2019, which decreases by 20% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 27, 2020.